| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.0006 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.002 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.26 | 0.02 |